Anti-PD-1/PD-L1/CTLA-4 inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-PD-1/PD-L1/CTLA-4 inhibitors, covering 2024-10-04 to 2024-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.